Press Releases

Orion Pharma Animal Health and Vetoquinol have announced their collaboration regarding the distribution of Orion's sedatives product family alpha-2 agonists and antagonist Dexdomitor, Domitor and Domosedan and Antisedan. Vétoquinol will be the distributor in selected...

Patheon has added a new filling technology that significantly reduces the time needed for formulation development and stability testing at its facility in Milton Park, UK. The Xcelodose 600 S Automated Encapsulator supports early phase development for oral dose...

An expert from Patheon will highlight the company's strategy for delivering exceptional customer experience through its integrated offerings at the Seventh Annual Global Biomanufacturing Summit. Dr Laura Parks, senior vice-president of corporate operations and strategic initiatives,...

Lonza has announced an agreement for the supply of TiGenix's eASC product, Cx601. Under the agreement, Lonza will manufacture material for the Phase III trial of Cx601 in the US at Lonza's cell therapy production facility in Walkersville, Maryland....

Boehringer Ingelheim, a research-based, global pharmaceutical company, and VTU Technology, a leading contract research and development company, announced today the renewal of their global Pichia pastoris technology collaboration agreement. VTU Technology, currently offering a very broad and versatile technology...

TxCell, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, today reports its revenues as of December 31, 2014 and updates on forthcoming milestones. ...

Dr. Parvinder Punia, Senior regulatory expert will present “European experience of harmonising the pharmaceutical market” at Moscow conference on February 10th 2015 Cambridge, UK, 2nd February 2015 – ELC Group, one of the fastest-growing providers of regulatory affairs, today...